Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 291Carcinoma, Non-Small-Cell Lung 206Prostatic Neoplasms 158Lung Neoplasms 93Stomach Neoplasms 69Neoplasms 69Head and Neck Neoplasms 60Squamous Cell Carcinoma of Head and Neck 56Neoplasm Metastasis 50Esophageal Neoplasms 49Ovarian Neoplasms 39Pancreatic Neoplasms 26Sarcoma 23Carcinoma, Ovarian Epithelial 20Urinary Bladder Neoplasms 19Unspecified Adult Solid Tumor, Protocol Specific 19Breast Neoplasms, Male 17Adenocarcinoma Of Esophagus 17Parkinson Disease 4, Autosomal Dominant Lewy Body 16Esophageal Squamous Cell Carcinoma 16Adenocarcinoma of Lung 16Fallopian Tube Neoplasms 14Carcinoma, Squamous Cell 14Adenocarcinoma 12Melanoma 11Inflammatory Breast Neoplasms 11Uterine Cervical Neoplasms 9Triple Negative Breast Neoplasms 9Salivary Gland Neoplasms 8Endometrial Neoplasms 8

Interventions

Oxaliplatin 4Fluorouracil 4Magnetic Resonance Spectroscopy 35,10-methylenetetrahydrofolic acid 3Ocoxin 2Leucovorin 2Irinotecan 2Cyclophosphamide 2Bevacizumab 2trifluridine tipiracil drug combination 1sintilimab 1pralsetinib 1pembrolizumab 1napabucasin 1huachansu 1guadecitabine 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1S-1 plus cisplatin 1Pharmaceutical Preparations 1Pemetrexed 1Paclitaxel 1Oviposition 1Levoleucovorin 1Infliximab 1Imatinib Mesylate 1Gemcitabine 1Exercise Test 1Drainage 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Diseases × Docetaxel × Clear all
NCT00526110 2016-10-31

Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed
98 enrolled 8 charts
Gastrointestinal

Gastrointestinal Diseases, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡